TrialCNS neuroscience & therapeutics2019

Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double-blind, placebo-controlled cross-over trial.

Kawita M S Kanhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.